Loading…
Attending this event?
View analytic
Wednesday, June 21 • 10:30am - 11:45am
#311: Next Generation Patient Recruitment: Part 2 of 2

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-514-L04-P; CME 1.25; IACET 1.25; RN 1.25

Patient recruitment remains a major cause of delay in today’s clinical trials, despite many patients indicating a willingness to participate in trials should opportunities arise. In this session, we explore experience with approaches to reach patients outside the clinic pool. We will explore why leveraging pharmacy has been unsuccessful to date, explore experience of leveraging primary care EHR tools to provide direct patient referrals, using artificial intelligence solutions to gain deeper and more focused insights from medical records data and the use of social listening and social media to present opportunities to potential participants. Security and privacy concerns will be considered.

Learning Objectives

Describe how the use of technology can help show potential study patients; Discuss the value and limitations machine learning can help on identifying potential study patients.

Chair

Neil Weisman

Speaker

Leveraging Patient-Centricity for Faster and More Cost-Efficient Patient Enrollment
Neil Weisman

One Compound/Many Indications: Connecting the Right Patients to the Right Trials Across Your Portfolio
Gwenn Oakes

Innovative Use of Social Media in Patient Recruitment
Kevin Bickford



Moderators
avatar for Neil Weisman

Neil Weisman

Executive Vice President and General Manager, Continuum Clinical
Neil Weisman, EVP and General Manager of Continuum Clinical, helps pharmaceutical and biotech companies bring new therapies to market faster and more efficiently by solving critical communication challenges that impact the clinical development process. With more than 15 years of... Read More →

Speakers
KB

Kevin Bickford

Executive Director, Clinical Operations, Health Decisions CRO
Kevin has worked in the clinical research industry for 20 years, contributing operational leadership and oversight for both Sponsors and CROs, across a wide range of therapeutic areas and trial designs. Kevin is currently Head of Clinical at Health Decisions, and is focused on pr... Read More →
GO

Gwenn Oakes

Senior Scientist, Clinical Research, Global Trial Optimization, Merck & Co., Inc.
Gwenn has been working as a member of the GTO group at Merck since 2014. Gwenn is currently responsible for multiple registration protocols in the Keytruda Lung program and serves as the Melanoma indication lead for GTO. At the program level, Gwenn initiated the Keynote Awareness... Read More →
avatar for Neil Weisman

Neil Weisman

Executive Vice President and General Manager, Continuum Clinical
Neil Weisman, EVP and General Manager of Continuum Clinical, helps pharmaceutical and biotech companies bring new therapies to market faster and more efficiently by solving critical communication challenges that impact the clinical development process. With more than 15 years of... Read More →


Wednesday June 21, 2017 10:30am - 11:45am
S501abc McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616